ABBOTT LABORATORIES·4

Feb 23, 5:40 PM ET

Morrone Louis H. 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2024

Insider Transaction Report

Form 4
Period: 2024-02-21
Morrone Louis H.
EXECUTIVE VICE PRESIDENT
Transactions
  • Award

    Common shares without par value

    2024-02-21+12,30967,224 total
  • Award

    Option (right to buy)

    2024-02-21+46,25746,257 total
    Exercise: $116.98From: 2025-02-21Exp: 2034-02-20Common Shares (46,257 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    2,556
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 21, 2024.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 15,419 on February 21, 2025, 15,419 on February 21, 2026, and 15,419 on February 21, 2027.

Documents

1 file
  • 4
    form4-02232024_100240.xmlPrimary